# Novartis Pharmaceuticals Corporation - Inspection Records

Source: https://www.globalkeysolutions.net/companies/novartis-pharmaceuticals-corporation/21559fd5-35ed-4cbd-b228-623dd76bcf47

> Inspection records and compliance data for Novartis Pharmaceuticals Corporation in Morris Plains, NJ. Access full analysis and detailed observations.

---

## Details

- Name: Novartis Pharmaceuticals Corporation
- FEI Number: 3010353512
- City: Morris Plains
- State: NJ
- Country Name: United States
- Address Line 1: 220 East Hanover Ave.
- Zip Code: 07950

## Related Documents

- [483 - Novartis Pharmaceuticals Corporation - Unknown Date](https://www.globalkeysolutions.net/records/483/novartis-pharmaceuticals-corporation/c31e1262-2601-41e1-b055-114f96464537) — source: FDA, date: Invalid Date
- [FDA Inspection 1300144 - Novartis Pharmaceuticals Corporation - 2026-02-06](https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharmaceuticals-corporation/dda9986d-7403-4915-9abe-66007c22736d) — source: FDA, date: February 6, 2026
- [483 - Novartis Pharmaceuticals Corporation - 2024-08-08](https://www.globalkeysolutions.net/records/483/novartis-pharmaceuticals-corporation/44e0cb23-0ec8-4334-bb8c-6f66a38965a7) — source: FDA, date: August 8, 2024
- [FDA Inspection 1245942 - Novartis Pharmaceuticals Corporation - 2024-08-08](https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharmaceuticals-corporation/d2f19248-2be2-424d-85b3-a50251928268) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 8, 2024
- [UNTITLED_LETTER - Novartis Pharmaceuticals Corporation - 2023-08-08](https://www.globalkeysolutions.net/records/untitled_letter/novartis-pharmaceuticals-corporation/cd26624a-3912-48a5-979f-444b80110332) — source: FDA, date: August 8, 2023
- [483 - Novartis Pharmaceuticals Corporation - 2022-12-09](https://www.globalkeysolutions.net/records/483/novartis-pharmaceuticals-corporation/b1680319-d6ed-404f-97d8-29d30a5966c6) — source: FDA, date: December 9, 2022
- [FDA Inspection 1194474 - Novartis Pharmaceuticals Corporation - 2022-12-09](https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharmaceuticals-corporation/016e211c-c215-46cc-85fd-3d8c24f49500) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 9, 2022
- [FDA Inspection 1194474 - Novartis Pharmaceuticals Corporation - 2022-12-09](https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharmaceuticals-corporation/323eee52-83d8-45f8-91b5-c1c3e4f83f89) — classification: No Action Indicated (NAI), source: FDA, date: December 9, 2022
- [483 - Novartis Pharmaceuticals Corporation - 2019-08-21](https://www.globalkeysolutions.net/records/483/novartis-pharmaceuticals-corporation/46e237ea-aa74-4167-91ef-3f93ae6e17f4) — source: FDA, date: August 21, 2019
- [FDA Inspection 1100101 - Novartis Pharmaceuticals Corporation - 2019-08-21](https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharmaceuticals-corporation/e4fab4a0-2d49-44f2-a6c8-f6170fd44cd2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 21, 2019

## Related Companies

- [Ipca Laboratories Limited](https://www.globalkeysolutions.net/companies/ipca-laboratories-limited/4221e8f5-a261-45fc-b9fc-d935bc1f225b)
- [Recipharm Monts](https://www.globalkeysolutions.net/companies/recipharm-monts/e3b2f0c3-26eb-4020-8127-76127e9e18d6)
- [Kite Pharma, Inc.](https://www.globalkeysolutions.net/companies/kite-pharma-inc/5bf88060-db53-466b-9a1c-85be7984894f)
- [FMKLABS](https://www.globalkeysolutions.net/companies/fmklabs/b335f624-1732-48b8-9900-26989b236b51)
- [Steril-Gene Life Sciences Private Ltd](https://www.globalkeysolutions.net/companies/steril-gene-life-sciences-private-ltd/0885ef5e-2fd7-42c0-927d-7cf3c2410eec)
- [Unexo Life Sciences Private Limited](https://www.globalkeysolutions.net/companies/unexo-life-sciences-private-limited/0a2a6fc8-1ef3-46dc-a2ca-f4eb344630e3)
- [V-Ensure Pharma Technologies Pvt. Limited](https://www.globalkeysolutions.net/companies/v-ensure-pharma-technologies-pvt-limited/01233430-1062-49f9-ad93-adf95ab293e8)
- [Celltrion Pharm, Inc.](https://www.globalkeysolutions.net/companies/celltrion-pharm-inc/481a4273-bf7e-4b37-8cd8-08b977ba576b)
- [Nectar Lifesciences Limited](https://www.globalkeysolutions.net/companies/nectar-lifesciences-limited/7b5dd8c8-0a38-4956-be6f-74871597ce80)
- [Modavar Pharmaceuticals](https://www.globalkeysolutions.net/companies/modavar-pharmaceuticals/9b63702d-7db4-4738-8b79-5f7fc9cd73d6)

## Related Officers

- [Douglas Davis](https://www.globalkeysolutions.net/people/douglas-davis/04ad04d8-bc13-4a5b-8f7c-7e6ed03f3d42)
- [Bojan Melekov](https://www.globalkeysolutions.net/people/bojan-melekov/2d7b5c6c-7d6a-43c1-8d82-4b51dd71d7b9)
- [investigator](https://www.globalkeysolutions.net/people/susan-m-jackson/2a4e01d1-8761-4d40-b493-69a4163473bb)
- [investigator](https://www.globalkeysolutions.net/people/kimberly-l-schultz/2d000290-f49c-4cfd-b8f8-3f4d71f76324)
- [Investigator](https://www.globalkeysolutions.net/people/unnee-ranjan/43f1d07e-4079-4d33-88a9-baf6a5df932c)
- [Investigator](https://www.globalkeysolutions.net/people/thai-d-truong/7395c128-0adb-44a1-8831-64673c98e93d)